Show simple item record

dc.contributor.author
De Luca, Roberto
dc.contributor.author
Kachel, Paul
dc.contributor.author
Kropivsek, Klara
dc.contributor.author
Snijder, Berend
dc.contributor.author
Manz, Markus G.
dc.contributor.author
Neri, Dario
dc.date.accessioned
2018-11-19T11:38:43Z
dc.date.available
2018-11-01T14:39:19Z
dc.date.available
2018-11-19T11:38:43Z
dc.date.issued
2018-05
dc.identifier.issn
1741-0126
dc.identifier.issn
1741-0134
dc.identifier.issn
0269-2139
dc.identifier.issn
1460-213X
dc.identifier.other
10.1093/protein/gzy015
en_US
dc.identifier.uri
http://hdl.handle.net/20.500.11850/300630
dc.language.iso
en
en_US
dc.publisher
Oxford University Press
en_US
dc.subject
CD38
en_US
dc.subject
IL2
en_US
dc.subject
immunocytokines
en_US
dc.subject
multiple myeloma
en_US
dc.subject
TRAIL
en_US
dc.title
A novel dual-cytokine–antibody fusion protein for the treatment of CD38-positive malignancies
en_US
dc.type
Journal Article
dc.date.published
2018-07-05
ethz.journal.title
Protein Engineering, Design & Selection
ethz.journal.volume
31
en_US
ethz.journal.issue
5
en_US
ethz.journal.abbreviated
Protein eng., design sel.
ethz.pages.start
173
en_US
ethz.pages.end
179
en_US
ethz.grant
Fulfilling Paul Ehrlich’s Dream: therapeutics with activation on demand
en_US
ethz.grant
Understanding and Exploiting the Molecular Targeting of Tumor Neo-vasculature
en_US
ethz.identifier.wos
ethz.identifier.scopus
ethz.publication.place
Oxford
en_US
ethz.publication.status
published
en_US
ethz.leitzahl
ETH Zürich::00002 - ETH Zürich::00012 - Lehre und Forschung::00007 - Departemente::02020 - Dep. Chemie und Angewandte Biowiss. / Dep. of Chemistry and Applied Biosc.::02534 - Institut für Pharmazeutische Wiss. / Institute of Pharmaceutical Sciences::03463 - Neri, Dario / Neri, Dario
en_US
ethz.leitzahl.certified
ETH Zürich::00002 - ETH Zürich::00012 - Lehre und Forschung::00007 - Departemente::02020 - Dep. Chemie und Angewandte Biowiss. / Dep. of Chemistry and Applied Biosc.::02534 - Institut für Pharmazeutische Wiss. / Institute of Pharmaceutical Sciences::03463 - Neri, Dario / Neri, Dario
en_US
ethz.grant.agreementno
670603
ethz.grant.agreementno
163479
ethz.grant.fundername
EC
ethz.grant.fundername
SNF
ethz.grant.funderDoi
10.13039/501100000780
ethz.grant.funderDoi
10.13039/501100001711
ethz.grant.program
H2020
ethz.grant.program
ethz.date.deposited
2018-11-01T14:39:38Z
ethz.source
FORM
ethz.eth
yes
en_US
ethz.availability
Metadata only
en_US
ethz.rosetta.installDate
2018-11-19T11:38:55Z
ethz.rosetta.lastUpdated
2019-01-03T09:37:01Z
ethz.rosetta.exportRequired
true
ethz.rosetta.versionExported
true
ethz.COinS
ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.atitle=A%20novel%20dual-cytokine%E2%80%93antibody%20fusion%20protein%20for%20the%20treatment%20of%20CD38-positive%20malignancies&rft.jtitle=Protein%20Engineering,%20Design%20&%20Selection&rft.date=2018-05&rft.volume=31&rft.issue=5&rft.spage=173&rft.epage=179&rft.issn=1741-0126&1741-0134&0269-2139&1460-213X&rft.au=De%20Luca,%20Roberto&Kachel,%20Paul&Kropivsek,%20Klara&Snijder,%20Berend&Manz,%20Markus%20G.&rft.genre=article&
 Search via SFX

Files in this item

FilesSizeFormatOpen in viewer

There are no files associated with this item.

Publication type

Show simple item record